Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 2 |
2018 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.
World J Gastroenterol. 2014 Apr 7;20(13):3516-24. doi: 10.3748/wjg.v20.i13.3516.
World J Gastroenterol. 2014.
PMID: 24707134
Free PMC article.
Review.
In recent years, a number of case reports and clinical studies have highlighted the risk of hepatitis B and C virus reactivation in patients with inflammatory bowel disease who are treated with immunosuppressive drugs. ...
In recent years, a number of case reports and clinical studies have highlighted the risk of hepatitis B and C virus reactivation in p …
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.
Guarino M, Sessa A, Cossiga V, Morando F, Caporaso N, Morisco F; Special Interest Group on “Hepatocellular carcinoma and new anti-HCV therapies” of the Italian Association for the Study of the Liver.
Guarino M, et al.
World J Gastroenterol. 2018 Jun 28;24(24):2582-2595. doi: 10.3748/wjg.v24.i24.2582.
World J Gastroenterol. 2018.
PMID: 29962815
Free PMC article.
Review.
With the introduction of direct-acting antiviral agents (DAA), the rate of sustained virological response (SVR) in the treatment of hepatitis C virus (HCV) has radically improved to over 95%. Robust scientific evidence supports a beneficial role of SVR after interferon the …
With the introduction of direct-acting antiviral agents (DAA), the rate of sustained virological response (SVR) in the treatment of hepatiti …
Item in Clipboard
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.
Bertoli A, Sorbo MC, Aragri M, Lenci I, Teti E, Polilli E, Di Maio VC, Gianserra L, Biliotti E, Masetti C, Magni CF, Babudieri S, Nicolini LA, Milana M, Cacciatore P, Sarmati L, Pellicelli A, Paolucci S, Craxì A, Morisco F, Palitti VP, Siciliano M, Coppola N, Iapadre N, Puoti M, Rizzardini G, Taliani G, Pasquazzi C, Andreoni M, Parruti G, Angelico M, Perno CF, Cento V, Ceccherini-Silberstein F; HCV Virology Italian Resistance Network (VIRONET-C).
Bertoli A, et al.
Sci Rep. 2018 Jun 12;8(1):8988. doi: 10.1038/s41598-018-26862-y.
Sci Rep. 2018.
PMID: 29895871
Free PMC article.
Clinical Trial.
Item in Clipboard
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology.
D'Amico G, Maruzzelli L, Airoldi A, Petridis I, Tosetti G, Rampoldi A, D'Amico M, Miraglia R, De Nicola S, La Mura V, Solcia M, Volpes R, Perricone G, Sgrazzutti C, Vanzulli A, Primignani M, Luca A, Malizia G, Federico A, Dallio M, Andriulli A, Iacobellis A, Addario L, Garcovich M, Gasbarrini A, Chessa L, Salerno F, Gobbo G, Merli M, Ridola L, Baroni GS, Tarantino G, Caporaso N, Morisco F, Pozzoni P, Colli A, Belli LS.
D'Amico G, et al.
J Hepatol. 2021 Dec;75(6):1355-1366. doi: 10.1016/j.jhep.2021.07.018. Epub 2021 Jul 30.
J Hepatol. 2021.
PMID: 34333100
Free article.
Three, 6 and 12-month mortality predictions were calculated by the 3 MELD versions: discrimination was assessed by c-statistics and calibration by comparing deciles of predicted and observed risks. ...A post hoc analysis revealed worse c-statistics in non-viral cirr …
Three, 6 and 12-month mortality predictions were calculated by the 3 MELD versions: discrimination was assessed by c-statistics and c …
Item in Clipboard
Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis.
Morisco F, Guarino M, La Bella S, Di Costanzo L, Caporaso N, Ayala F, Balato N.
Morisco F, et al.
BMC Gastroenterol. 2014 Dec 19;14:214. doi: 10.1186/s12876-014-0214-x.
BMC Gastroenterol. 2014.
PMID: 25523080
Free PMC article.
Item in Clipboard
Cite
Cite